AMD shares fell 4.8% yesterday, caught in a broad semiconductor selloff that had little to do with the chipmaker’s own operations. Reuters attributed the weakness primarily to Intel’s disappointing outlook for the fourth quarter and warnings about soft PC demand, which weighed on chip stocks across the board. AMD was among the names hit by the negative shift in sentiment in after-hours trading.
The downdraft also followed an earlier retreat in the semiconductor sector triggered by Alphabet’s results, where concerns about the returns on AI infrastructure spending came into focus. That broader anxiety — whether the enormous sums being poured into AI capacity will ever generate adequate profits — has become the backdrop against which AMD’s own AI ambitions are now being judged.
A Selloff Built on Outside News
The distinction matters. A weaker Intel forecast is not an AMD business result, and worries about Alphabet’s cash flows do not demonstrate any operational deterioration at AMD. What they change is the market’s view of the investments AMD is tied to through its partnerships. Reuters framed the decline chiefly as a reaction to Intel’s guidance and the sour mood in the chip sector — a reading that cautions against treating a wide selling wave as a company-specific verdict.
Susquehanna, for its part, moved in the opposite direction. Analyst Christopher Rolland reportedly lifted his price target on AMD from $620 to $650 on Wednesday while keeping his “Positive” rating. Not everyone was buying the dip, though: ARK Invest disclosed Wednesday that it had sold AMD shares on Tuesday, following reported sales the day before.
Meta Ties Deepen, but Deployment Is Not Yet Profit
AMD’s collaboration with Meta spans processors, graphics chips, networking technology, systems and software. According to the company, the first Helios systems are installed at Meta and undergoing testing. AMD also announced a $1 billion investment in Meta’s equity offering.
Should investors sell immediately? Or is it worth buying AMD?
That is more concrete than a mere statement of intent about technological possibilities — but installed systems under test are not the same as a completed, broad-scale rollout. And a partnership, on its own, does not answer the question of whether AI spending pays off economically. What matters on the exchange is a stricter test of commercial viability: how much additional infrastructure gets built is one question; what that infrastructure earns its operators is another.
Oracle and Intel Add Breadth
The Meta work is not AMD’s only front. On Tuesday the company announced an expanded collaboration with Oracle covering AI and cloud infrastructure. Oracle Cloud Infrastructure’s forthcoming Compute E7 instances are set to use sixth-generation AMD EPYC processors, while AMD Pensando DPUs will support Oracle’s converged Acceleron network cards for AMD-based instances.
AMD and Intel, meanwhile, announced a software-optimization partnership on October 20. The two rivals plan to merge their optimization work for x86 processors in the PyTorch environment into oneDNN, giving developers a single software path for chips from both vendors.
The November 3 Reckoning
The next hard look at AMD’s business comes with its third-quarter 2026 results, scheduled for release after the market close on November 3, 2026, followed by a conference call. Until then, keeping the threads apart is essential: the partnerships describe concrete collaboration, while the recent selling pressure reflects doubts about the economic return on the wider AI buildout. Both belong in any assessment of the stock — but they are not the same thing.
Ad
AMD Stock: Buy or Sell?! New AMD Analysis from October 30 delivers the answer:
The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 30.
AMD: Buy or sell? Read more here...
